Integra Lifesciences News - Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase. Integra lifesciences announces definitive agreement to acquire surgical innovation. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or.
Integra LifeSciences logo in transparent PNG format
Integra lifesciences announces definitive agreement to acquire surgical innovation. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or. Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase.
Integra LifeSciences Launches the Integra® Panta® 2 TTC Arthrodesis
Integra lifesciences announces definitive agreement to acquire surgical innovation. Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or.
Integra LifeSciences celebrates opening of new global headquarters
Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or. Integra lifesciences announces definitive agreement to acquire surgical innovation.
Integra LifeSciences Opens New Center of Innovation and Learning
Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase. Integra lifesciences announces definitive agreement to acquire surgical innovation. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or.
Integra LifeSciences Appoints Renee Lo as Director
Integra lifesciences announces definitive agreement to acquire surgical innovation. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or. Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase.
Integra LifeSciences Columbia
Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or. Integra lifesciences announces definitive agreement to acquire surgical innovation. Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase.
Integra LifeSciences Announces Positive Clinical Results
Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase. Integra lifesciences announces definitive agreement to acquire surgical innovation. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or.
Integra LifeSciences Launches NeuraGen® 3D Nerve Guide Matrix
Integra lifesciences announces definitive agreement to acquire surgical innovation. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or. Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase.
Integra LifeSciences Celebrates New Global Headquarters New Jersey
Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase. Integra lifesciences announces definitive agreement to acquire surgical innovation. Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or.
Why Integra LifeSciences (IART) Stock Is Plunging Today
Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or. Integra lifesciences announces definitive agreement to acquire surgical innovation. Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase.
Web adjusted ebitda for the first quarter of 2024 was $71.8 million, or 19.5% of revenue, compared to $92.3 million, or. Reported revenues were $398.0 million, representing a decrease of 1.8% on a reported basis and an increase. Integra lifesciences announces definitive agreement to acquire surgical innovation.